BOUYGUES: Disclosure of trading in own shares
Tweet
Share
E-mailREGULATED INFORMATION
DISCLOSURE OF TRADING IN OWN SHARES
Paris, 23/09/2024
Disclosure of trading in own shares on 16 and 17 September 2024.
As part of the authorisation granted by the Annual General Meeting of 25 April 2024
I. Summary presentation
| Name of issuer | Identity code of issuer | Transaction date | Identity code of financial instrument | Total daily volume traded (number of shares) | Daily weighted average price of shares purchased | Market |
| BOUYGUES SA | 969500MOCLNQFNZN0D63 | 16 september 2024 | FR0000120503 | 41,500 | 31.8244 | XPAR |
| BOUYGUES SA | 969500MOCLNQFNZN0D63 | 17 september 2024 | FR0000120503 | 65,000 | 32.3036 | XPAR |
II. Detailed presentation
https://www.bouygues.com/wp-content/uploads/2024/09/2024-09-23-tableau-de-declaration-a-j7-des-operations-de-rachat.xlsx
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BranchOut Secures Approximately $750,000 in Initial Orders for New Front-of-Club Multipack Product Line and Dried Cheesecake Bites with Nation's Largest Warehouse Club Retailer
- Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push
- CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
